BIOTALENTUM
DEAD

Serial Number

79387984

Owner

Biotalentum Kft.

Filing Date

Oct 26, 2023

Add to watchlist:

No watchlists yet
View on USPTO

BIOTALENTUM Trademark

Serial Number: 79387984

BIOTALENTUM is a trademark filed by Biotalentum Kft. on October 26, 2023. The trademark is classified under Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently no longer active.

Owner Contact Info

Biotalentum Kft.

Aulich Lajos u. 26.

Entity Type: 16

Trademark Details

Filing Date

October 26, 2023

Registration Date

Not Registered

Goods & Services

Medical research; medical research laboratory services; dna analysis services for scientific research purposes

Medical evaluation services; medical treatment services; regenerative medicine services; advisory services relating to medical services; cultured cell bank services for medical transplantation; medical diagnostic services [testing and analysis]

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Feb 5, 2026 FINT
FINAL DISPOSITION NOTICE SENT TO IB
Jan 16, 2026 FICS
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jan 16, 2026 FICR
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Jul 11, 2025 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jun 24, 2025 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Jun 24, 2025 OPNR
ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Jan 16, 2025 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Jan 16, 2025 ABN2
REFUSAL PROCESSED BY IB
Jul 21, 2024 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jul 2, 2024 RFCS
REFUSAL PROCESSED BY MPU
Jul 2, 2024 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jun 15, 2024 RFCR
NON-FINAL ACTION WRITTEN
Jun 12, 2024 CNRT
ASSIGNED TO EXAMINER
Jun 9, 2024 DOCK
NEW REPRESENTATIVE AT IB RECEIVED
Apr 20, 2024 NREP
NEW REPRESENTATIVE AT IB RECEIVED
Apr 20, 2024 NREP
APPLICATION FILING RECEIPT MAILED
Jan 30, 2024 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 26, 2024 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jan 25, 2024 REPR